- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04412278
Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers
June 8, 2020 updated by: Begüm Okudan, Okan University
Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers: Cross Sectional Study on Turkish Society and Interpretation With Physical Activity Level
It is aimed to determine the physical activity level and exercise benefits and barriers caused by Covid-19 pandemic and reveal the relationship between them.
Study Overview
Detailed Description
Study hypothesis that people are tend to be physically inactive while Covid-19 pandemic.
It is aimed to determine the exercise benefits and barriers caused by Covid-19 pandemic and reveal the relationship among gender, age, marial status and physical activity level.
Study Type
Observational
Enrollment (Actual)
392
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34959
- Istanbul Okan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The population of the individuals between 15 - 65 ages in Turkey is 56.391.925
people.
It is calculated that there are 42.463.119
individuals cover the criterion as universe of the study.
Description
Inclusion Criteria:
- being Turkish
- understanding Turkish
- being between the age of 15 - 65
- being literate
- have internet access
Exclusion Criteria:
- having a disable condition to exercise
- having missing value on outcome measures
- giving incomprehensible answering
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Turkish society
Individuals speak Turkish and lives in Turkey, ages between 15 - 65, literate and with internet access
|
Volunteer individuals enrolled the study after approval an online informed consent form.
Sociodemographic data of the participants recorded as an online survey.
Then, patient reported outcomes were used to assess physical activity level (International Physical Actvity Questionairre) and Exercise Benefits and Barriers (Exercise Benefits and Barriers Scale).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise Benefits and Barriers Scale
Time Frame: three months after Covid 19 recognised as pandemic
|
The Exercise Benefits/Barriers Scale (EBBS) was developed in response to a need for an instrument to determine perceptions of individuals concerning the benefits of and barriers to participating in exercise.
The instrument may be scored and used in its entirety or as two separate scales.
The instrument has a four-response, forced-choice Likert-type format with responses ranging from 4 (strongly agree) to 1 (strongly disagree).
Scores on the total instrument can range from 43 to 172.
The higher the score, the more positively the individual perceives exercise.
When the Benefits Scale is used alone, the score range is between 29 and 116.
When the Barriers Scale is used alone, scores range between 14 and 56.
If used alone, the Barriers Scale does not need to be reverse-scored.
In this instance, the higher the score on the Barriers Scale, the greater the perception of barriers to exercise.
|
three months after Covid 19 recognised as pandemic
|
Sociodemographic information
Time Frame: three months after Covid 19 recognised as pandemic
|
Participants will be asked to give information about: age, gender, educational status, height, weight, occupation, working status, whether they have a chronic disease.
|
three months after Covid 19 recognised as pandemic
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Physical Activity Questionairre
Time Frame: three months after Covid 19 recognised as pandemic
|
The IPAQ-S developed for participants to report activities performed for at least 10 minutes during the last 7 days.
Respondents will be asked to report time spent in physical activity performed across leisure time, work, domestic activities, and transport at each of 3 intensities: walking, moderate, and vigorous.
Using the instrument's scoring protocol total weekly physical activity was estimated by weighting time spent in each activity intensity with its estimated metabolic equivalent (MET) energy expenditure.
The IPAQ scoring protocol assigns the following MET values to walking, moderate, and vigorous intensity activity: 3.3 METs, 4.0 METs, and 8.0 METs, respectively.
Participants will be considered to have met American Collage of Sports Medicine physical activity recommendations.
if they reported at least 150 min/wk of walking, moderate, or vigorous intensity physical activity.
|
three months after Covid 19 recognised as pandemic
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Actual)
June 8, 2020
Study Completion (Actual)
June 8, 2020
Study Registration Dates
First Submitted
May 30, 2020
First Submitted That Met QC Criteria
May 30, 2020
First Posted (Actual)
June 2, 2020
Study Record Updates
Last Update Posted (Actual)
June 11, 2020
Last Update Submitted That Met QC Criteria
June 8, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 500600127
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data wil be stored by researches, if needed for scientific purposes, it can be discussed to share .
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID
-
European Institute of OncologyFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Azienda Ospedaliera... and other collaboratorsCompleted
-
Owlstone LtdCambridge University Hospitals NHS Foundation TrustCompleted
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Sultan Qaboos UniversityCompletedCOVID-19 | Non-CovidOman
-
Assiut UniversityRecruiting
-
Jilin UniversityUnknown
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Miami VA Healthcare SystemNot yet recruiting
Clinical Trials on Online Survey
-
Tomsk National Research Medical Center of the Russian...RecruitingCOVID-19 | Risk Factors | Polypharmacy | Drug Interactions | Self MedicationRussian Federation
-
Jaseng Medical FoundationCompletedFractures, Bone | Medicine, Korean TraditionalKorea, Republic of
-
Hasselt UniversityRecruitingPhysical Activity | Chronic Musculoskeletal Disease | Exercise Intensity | Online SurveyBelgium
-
Virginia Polytechnic Institute and State UniversityNot yet recruitingSubstance Use Disorders
-
Virginia Polytechnic Institute and State UniversityRecruitingAlcohol Use DisorderUnited States
-
Northwestern UniversityEpidermolysis Bullosa Research PartnershipActive, not recruiting
-
University Hospital, GhentCompletedQuality of Life | Mental HealthBelgium
-
Universidad Miguel Hernandez de ElchePontificia Universidad Catolica de Chile; University of Sao Paulo; Universidad... and other collaboratorsCompletedAcute Stress DisorderChile, Argentina, Colombia, Ecuador, Spain
-
University of WashingtonCompletedOnline TherapyUnited States